Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Gains from Investment Securities (2016 - 2025)

Milestone Scientific's Gains from Investment Securities history spans 15 years, with the latest figure at $2278.0 for Q1 2025.

  • For Q1 2025, Gains from Investment Securities fell 8.07% year-over-year to $2278.0; the TTM value through Mar 2025 reached $9936.0, up 2.62%, while the annual FY2024 figure was $3.0 million, 2.8% down from the prior year.
  • Gains from Investment Securities for Q1 2025 was $2278.0 at Milestone Scientific, down from $2523.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $2.5 million in Q2 2021 and bottomed at $1883.0 in Q1 2021.
  • The 5-year median for Gains from Investment Securities is $2278.0 (2025), against an average of $152345.0.
  • The largest annual shift saw Gains from Investment Securities surged 140494.94% in 2021 before it plummeted 97.41% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $2869.0 in 2021, then dropped by 28.27% to $2058.0 in 2022, then soared by 39.94% to $2880.0 in 2023, then fell by 12.4% to $2523.0 in 2024, then decreased by 9.71% to $2278.0 in 2025.
  • Per Business Quant, the three most recent readings for MLSS's Gains from Investment Securities are $2278.0 (Q1 2025), $2523.0 (Q4 2024), and $2595.0 (Q3 2024).